About: Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Darin A Wick et al published January 2011 in Vaccine

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2011 (uk) im Jahr 2011 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en janvier 2011 (fr) scholarly article by Darin A Wick et al published January 2011 in Vaccine (en)
publication date	wds:Q60683147-2118A786-8A88-40F8-AAEA-87FEF1DC3BF1
publication date	2011-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60683147-57C4CE18-5B4E-4AFA-B1B5-6750DB8DF5F6
language of work or name	English
cites work	wds:Q60683147-005BFF29-A6B4-440B-BD46-0A97C29A7AA8 wds:Q60683147-050D9E94-37FD-48F2-AD45-073E3B737818 wds:Q60683147-072FE380-1CBB-4CF2-93D1-F1399458656F wds:Q60683147-07F03B44-341F-40A2-A6A3-E5FF9490B69C wds:Q60683147-1382639F-E7D8-43C4-8C27-A98357A6ADCD wds:Q60683147-14E1DE5E-1B72-4C31-9A92-0687F1425A30 wds:Q60683147-195F76BE-C28E-4700-A5FB-764FAF8CC7CE wds:Q60683147-20D94E6F-8069-48BC-906C-013D515BD0B3 wds:Q60683147-2A3B7867-9450-4390-A677-AE8EC6C88AE5 wds:Q60683147-34995EF8-6D3B-4BAA-9E17-82EE578F58A2 wds:Q60683147-445C2DA5-4529-4440-B9CC-A7B79D0FF5CD wds:Q60683147-47DF7EC7-4A7F-4F92-8ACE-A7A47E9867B8 wds:Q60683147-5B545A11-FB95-4FC0-9E67-6660B0B0838E wds:Q60683147-5CE7B6D7-ED0C-4E8A-B2CE-F14501F06970 wds:Q60683147-5DD9BFC7-7915-4D41-B4BB-7C5F6483FDA6 wds:Q60683147-6536EA9F-1CFE-4329-A2F2-6E2353078F0F wds:Q60683147-86FCB07C-DC68-436C-9C96-F6EA9F9D5B22 wds:Q60683147-90E93A10-C3F5-41AC-9E51-3483D39BAC54 wds:Q60683147-9F8FBD1A-AC90-465E-9A59-A675AE1652C7 wds:Q60683147-A2721028-2FE9-4477-9527-F51CCF5F1CA3 wds:Q60683147-B38B7F17-14D4-4C3B-AFA5-EF59DC8091A4 wds:Q60683147-BCD589DD-AB82-4BCB-88AC-C37B90782F1F wds:Q60683147-BE41D805-27FD-4E86-A310-0B39CD19C010 wds:Q60683147-C39B8413-66B2-4CEC-ACEA-A655B17A4871 wds:Q60683147-C7F3EA76-CB30-4BF2-AA4D-AED20F72545D wds:Q60683147-C99CAF6B-A2C0-4272-A911-37588D896176 wds:Q60683147-D5073243-6948-48AD-9BBE-483AD33F1445 wds:Q60683147-D9A7650E-0F81-43B3-B317-3B4ED2C5BB86 wds:Q60683147-E0DBDA68-52B3-4B4C-8636-101E6FC907B0 wds:Q60683147-E990DB01-A7CF-44ED-94F3-C626B9B946A4 wds:Q60683147-ED159370-78D8-475B-8329-A178BC9A7693 wds:Q60683147-F2574402-0BE4-4E12-BA82-8255254DA7C0 wds:Q60683147-F88E518B-72D9-4714-A17A-B03C399C96F0
cites work	Twelve immunotherapy drugs that could cure cancers Strategies for designing and optimizing new generation vaccines Vaccines: past, present and future CD8+ T cell efficacy in vaccination and disease Sipuleucel-T immunotherapy for castration-resistant prostate cancer Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Heterologous prime-boost vaccination. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo Cancer immunoediting: from immunosurveillance to tumor escape CD8 T cell expansion and memory differentiation are facilitated by simultaneous and sustained exposure to antigenic and inflammatory milieu. Jump-starting the immune system: prime-boosting comes of age. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Viruses as vaccine vectors for infectious diseases and cancer Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding Killer T cells regulate antigen presentation for early expansion of memory, but not naive, CD8+ T cell Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells Cutting edge: polyinosinic:polycytidylic acid boosts the generation of memory CD8 T cells through melanoma differentiation-associated protein 5 expressed in stromal cells. A comparison and critical analysis of preclinical anticancer vaccination strategies Design and development of synthetic peptide vaccines: past, present and future Viral immunity: cross-priming with the help of TLR3. Randomized trial of standard therapy with or without poly I:C in patients with superficial bladder cancer Exuberated numbers of tumor-specific T cells result in tumor escape.
author name string	wds:Q60683147-CCD8C148-1C1F-426F-A472-016F7D04D8FC wds:Q60683147-E25E6122-84EA-4601-A20A-F4A5388B7F43
author name string	John R Webb Darin A Wick
rdfs:label	Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C) (en) Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly (nl)
skos:prefLabel	Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C) (en) Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly (nl)
name	Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C) (en) Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly (nl)
author	wds:Q60683147-41F4C050-6B6F-4508-B016-A03E1EEB6DE6 wds:Q60683147-734A688D-81D5-4935-B985-74EDF2E5A4E9
author	Brad H Nelson Spencer D. Martin
title	wds:Q60683147-46D2E4D0-EB6D-4CB4-B1D9-0409E81F7574
title	Profound CD8+ T cell immunity elicited by sequential daily immunization with exogenous antigen plus the TLR3 agonist poly(I:C) (en)
page(s)	wds:Q60683147-AC7BC161-9ED6-47DA-8D4F-C3672F601881
page(s)	984-993
instance of	wds:Q60683147-D034A01A-89FD-42AF-86AF-0C328ADFC1F5
instance of	scholarly article
main subject	wds:Q60683147-101C9EB7-368B-4B3B-B2B7-93E6DD19E325 wds:Q60683147-900F08B3-4806-44EA-B807-9A33448A1E76
main subject	molecular medicine infectious disease

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software